Pfizer/BioNTech vaccine neutralises U.K. SARS-CoV-2 strain in early study
Pfizer and BioNTech have published early in vitro study data showing that the BNT162b2 COVID-19 vaccine generates antibodies that neutralise
Read morePfizer and BioNTech have published early in vitro study data showing that the BNT162b2 COVID-19 vaccine generates antibodies that neutralise
Read moreThe 20 min high-throughput assay estimates the binding of drugs to human serum albumin (HSA) and a1-acid glycoprotein (AGP) to
Read moreThe 20 min high-throughput assay kit estimates the binding of drugs to human serum albumin (HSA) and predicts the plasma
Read moreRoche revealed a new collaboration agreement with Moderna to use the Elecsys® Anti-SARS-CoV-2 S antibody assay in Moderna’s COVID-19 vaccine
Read moreThe 20 min high-throughput assay estimates the binding of drugs to a1-acid glycoprotein (AGP) and is essential for predicting plasma
Read moreThe 20 min assay measures the affinity of drugs to human microsomal membranes and determines microsomal binding in stability incubation
Read morePredicting the pharmacokinetics of new chemical entities in humans is a powerful ability for drug discovery and development. Off-the-shelf Intestinal
Read moreThe new versatile plasma protein binding assay for sticky and tightly bound compounds can be used with plasma from any
Read moreAn off the shelf high-throughput assay kit for brain tissue binding and brain disposition. Brain Tissue Binding Assay The TRANSIL
Read moreEnzolytics, Inc, a drug development company with a focus on debilitating infectious diseases, announced on September 16, the execution of
Read more